StockEdge.com
  • Go Premium
    • StockEdge Quarterly Plan
    • StockEdge Annual Plan
    • StockEdge Analyst
    • StockEdge Club
    • Compare Plans
StockEdge Blog
  • Trending Stocks
  • Insights
    • All
    • Business Houses
    • Markets themes
    • Stock Insights
    How Page Industries is creating a “branded” opportunity in a fragmented market

    How Page Industries is creating a “branded” opportunity in a fragmented market

    5 Stocks which are Consistently Paying Dividend

    5 Stocks which are Consistently Paying Dividend

    Elgi Equipments – Enjoying Strong Tailwinds

    Elgi Equipments – Enjoying Strong Tailwinds

    J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

    J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

    Blue Dart Express – A market leader in Air Express Industry

    Blue Dart Express – A market leader in Air Express Industry

    Hindustan Foods – A market leader in FMCG contract manufacturing

    Hindustan Foods – A market leader in FMCG contract manufacturing

    Sharda Cropchem – Ending the year with a strong performance in Q4FY22

    Sharda Cropchem – Ending the year with a strong performance in Q4FY22

    ABB India – An outstanding overall performance

    ABB India – An outstanding overall performance

    Apcotex Industries Ltd. – Strongly Outperforming

    Apcotex Industries Ltd. – Strongly Outperforming

  • Technical Analysis
    Derivative Analytics

    Derivative Analytics – An Insightful Research Tool

    Put-Call Ratio – A Powerful Derivatives Indicator

    Put-Call Ratio – A Powerful Derivatives Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    Technical Analysis using Edge Charts

    Technical Analysis using Edge Charts

    Adaptive Relative Strength & Static Relative Strength Scans

    Adaptive Relative Strength & Static Relative Strength Scans

    SuperTrend Indicator : Sell or Buy Signals

    SuperTrend Indicator : Sell or Buy Signals

    2 year and 5 year Price Breakout Scans

    2 year and 5 year Price Breakout Scans

    What is Narrow Range Scans (NR)

    What is Narrow Range Scans (NR)

    Relative Strength (RS)

    Relative Strength (RS)

  • Fundamental Analysis
    • All
    • Cash Flow Ratios
    • Efficiency ratios
    • Growth Ratios
    • Liquidity Ratios
    • Return Ratios
    • Solvency ratios
    • Valuation Ratios
    Understanding the Importance of creating Fundamental Scans

    Understanding the Importance of creating Fundamental Scans

    Using My Combination Scan to Identify best in an Industry

    Using My Combination Scan to Identify best in an Industry

    Cost Income ratio

    Cost to Income Ratio(%)

    Cost of Liability

    Cost of Liabilities (%)

    Operating Cost to Assets Ratio (%)

    Operating Cost to Assets Ratio (%)

    Promoter pledge

    Promoter Pledge: Know Everything about it

  • StockEdge Tutorials
    StockEdge Version 8.1 – It keeps getting Better & Better

    StockEdge Version 8.1 – It keeps getting Better & Better

    StockEdge Version Update 8.0 – Like never before

    StockEdge Version Update 8.0 – Like never before

    Derivative Analytics

    Derivative Analytics – An Insightful Research Tool

    Market Breadth – A Bird’s Eye View of the Market at 1 place

    Market Breadth – A Bird’s Eye View of the Market at 1 place

    StockEdge Version 7.6 released – Enhancing your investment journey further!

    StockEdge Version 7.6 released – Enhancing your investment journey further!

    Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

    Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

    Beta & Beta Scans – A Powerful Technical Indicator

    Beta & Beta Scans – A Powerful Technical Indicator

    StockEdge Version Update 7.4 – Enhancing your Investment Journey

    StockEdge Version Update 7.4 – Enhancing your Investment Journey

    StockEdge 7.3 Release

    StockEdge 7.3 Release

  • Mutual Fund
    Top 5 Mutual Funds for 2022 where you can start your SIP

    Top 5 Mutual Funds for 2022 where you can start your SIP

    What are Value Funds and its Advantages?

    What are Value Funds and its Advantages?

    A Beginners Guide to Thematic Funds

    A Beginners Guide to Thematic Funds

    Understanding Sector Funds and their Benefits to our Portfolio

    Understanding Sector Funds and their Benefits to our Portfolio

    Are Dividend Yield Funds a good option to invest in?

    Are Dividend Yield Funds a good option to invest in?

    What are Contra Funds and their advantages?

    What are Contra Funds and their advantages?

    Trending Tags

    No Result
    View All Result
    • Trending Stocks
    • Insights
      • All
      • Business Houses
      • Markets themes
      • Stock Insights
      How Page Industries is creating a “branded” opportunity in a fragmented market

      How Page Industries is creating a “branded” opportunity in a fragmented market

      5 Stocks which are Consistently Paying Dividend

      5 Stocks which are Consistently Paying Dividend

      Elgi Equipments – Enjoying Strong Tailwinds

      Elgi Equipments – Enjoying Strong Tailwinds

      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      Blue Dart Express – A market leader in Air Express Industry

      Blue Dart Express – A market leader in Air Express Industry

      Hindustan Foods – A market leader in FMCG contract manufacturing

      Hindustan Foods – A market leader in FMCG contract manufacturing

      Sharda Cropchem – Ending the year with a strong performance in Q4FY22

      Sharda Cropchem – Ending the year with a strong performance in Q4FY22

      ABB India – An outstanding overall performance

      ABB India – An outstanding overall performance

      Apcotex Industries Ltd. – Strongly Outperforming

      Apcotex Industries Ltd. – Strongly Outperforming

    • Technical Analysis
      Derivative Analytics

      Derivative Analytics – An Insightful Research Tool

      Put-Call Ratio – A Powerful Derivatives Indicator

      Put-Call Ratio – A Powerful Derivatives Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      Technical Analysis using Edge Charts

      Technical Analysis using Edge Charts

      Adaptive Relative Strength & Static Relative Strength Scans

      Adaptive Relative Strength & Static Relative Strength Scans

      SuperTrend Indicator : Sell or Buy Signals

      SuperTrend Indicator : Sell or Buy Signals

      2 year and 5 year Price Breakout Scans

      2 year and 5 year Price Breakout Scans

      What is Narrow Range Scans (NR)

      What is Narrow Range Scans (NR)

      Relative Strength (RS)

      Relative Strength (RS)

    • Fundamental Analysis
      • All
      • Cash Flow Ratios
      • Efficiency ratios
      • Growth Ratios
      • Liquidity Ratios
      • Return Ratios
      • Solvency ratios
      • Valuation Ratios
      Understanding the Importance of creating Fundamental Scans

      Understanding the Importance of creating Fundamental Scans

      Using My Combination Scan to Identify best in an Industry

      Using My Combination Scan to Identify best in an Industry

      Cost Income ratio

      Cost to Income Ratio(%)

      Cost of Liability

      Cost of Liabilities (%)

      Operating Cost to Assets Ratio (%)

      Operating Cost to Assets Ratio (%)

      Promoter pledge

      Promoter Pledge: Know Everything about it

    • StockEdge Tutorials
      StockEdge Version 8.1 – It keeps getting Better & Better

      StockEdge Version 8.1 – It keeps getting Better & Better

      StockEdge Version Update 8.0 – Like never before

      StockEdge Version Update 8.0 – Like never before

      Derivative Analytics

      Derivative Analytics – An Insightful Research Tool

      Market Breadth – A Bird’s Eye View of the Market at 1 place

      Market Breadth – A Bird’s Eye View of the Market at 1 place

      StockEdge Version 7.6 released – Enhancing your investment journey further!

      StockEdge Version 7.6 released – Enhancing your investment journey further!

      Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

      Using Investor Portfolios Section to track Big Bulls like Rakesh Jhunjhunwala

      Beta & Beta Scans – A Powerful Technical Indicator

      Beta & Beta Scans – A Powerful Technical Indicator

      StockEdge Version Update 7.4 – Enhancing your Investment Journey

      StockEdge Version Update 7.4 – Enhancing your Investment Journey

      StockEdge 7.3 Release

      StockEdge 7.3 Release

    • Mutual Fund
      Top 5 Mutual Funds for 2022 where you can start your SIP

      Top 5 Mutual Funds for 2022 where you can start your SIP

      What are Value Funds and its Advantages?

      What are Value Funds and its Advantages?

      A Beginners Guide to Thematic Funds

      A Beginners Guide to Thematic Funds

      Understanding Sector Funds and their Benefits to our Portfolio

      Understanding Sector Funds and their Benefits to our Portfolio

      Are Dividend Yield Funds a good option to invest in?

      Are Dividend Yield Funds a good option to invest in?

      What are Contra Funds and their advantages?

      What are Contra Funds and their advantages?

      Trending Tags

      No Result
      View All Result
      StockEdge Blog
      Home Insights
      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      J.B. Chemicals & Pharmaceuticals – One of India’s fastest-growing pharmaceutical companies

      StockEdge by StockEdge
      June 5, 2022
      Reading Time: 7 mins read
      33.3k
      VIEWS
      Share on FacebookShare on TwitterShare On WhatsApp

      Table of Contents

      • The Story
      • New Jockey with a good track record
      • Key Steps taken by the New Jockey
      • Diversification into new therapies
      • Acquisitions to enter new therapies.
      • Become a global CMO leader
      • The company’s leading brands include
      • Let’s look at the Financials of J.B. Chemicals & Pharmaceuticals Ltd.
      • To get more detailed analysis and Reports on Stocks, visit our Edge Report Section by subscribing to our StockEdge premium plans.

      In this weekend’s Stock Insights, we will discuss one of India’s fastest-growing pharmaceutical companies, i.e. J.B. Chemicals & Pharmaceuticals Ltd.

      The Story

      Established in 1976, J.B. Chemicals & Pharmaceuticals Ltd. is one of India’s fastest-growing pharmaceutical companies.

      J.B. Chemicals & Pharmaceuticals Ltd. is trusted by healthcare professionals worldwide as an integrated, research-oriented, publicly-traded organization focusing on supplying affordable, high-quality products in both domestic and international markets.

      J.B. Chemicals & Pharmaceuticals Ltd. exports to over 30 countries and earns more than half of its revenue from international sales. The company is dedicated to producing a wide range of innovative speciality products such as tablets, injectables (vials, ampoules, form fill seal), creams and ointments, lozenges, herbal liquids, and capsules.

      The company is well-known for providing high-quality products in chronic and acute therapeutic segments such as cardiovascular, gastroenterology, anti-infective, and pain management (Rantac, Metrogyl and Nicardia).

      KKR (a P.E. player) recently acquired a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. and now owns 54%of the company through its subsidiary Tau Investment Holdings Pte Ltd.

      Download StockEdge App Download StockEdge App Download StockEdge App
      J.B. Chemicals

      New Jockey with a good track record

      The new management team appointed has mostly been recruited from Cipla, the leader in the Indian respiratory market.

      On October 5, 2020, KKR appointed Mr Nikhil Chopra as CEO. He was previously the CEO of Cipla‘s India business, and he has worked for the company for over 24 years.

      Other senior management appointments include Mr Dilip Singh Rathore and Mr Kunal Khanna, who have significant experience in Cipla.

      The new management team has already launched the respiratory division (non-inhaler), tapped into the existing sales force for newer therapies, and made a few acquisitions to diversify into newer therapies.

      Key Steps taken by the New Jockey

      The new team has taken encouraging steps, which include:

      • Diversification into new therapies in India, leveraging the new team’s prior experience.
      • Re-organizing the existing field force so that no new sales force was required for new therapies.
      • Accelerating the life cycle management of legacy brands.
      • Completing two acquisitions in India with good synergy potential.
      • The medium-term goal is to be among India’s Top 20 pharmaceutical companies.

      Diversification into new therapies

      Respiratory and paediatric medicine: New management has a strong background in building brands in the respiratory segment in India, having previously worked at Cipla.

      As a result, the NOVA division was established for respiratory and paediatric therapies, with a sales force of 350 people.

      The division would concentrate on idiopathic pulmonary fibrosis, pulmonary hypertension, etc. Akair LC (levocetirizine + montelukast), Nintabid (nintedanib), and Viscojoy (acetylcysteine + acebrophylline) are its respiratory brands.

      Nephrology: The RENOVA division was formed to promote nephrology brands. Through the Cilacar and Nicardia brands, the company has strong brand equity with nephrologists. It intends to use this to promote other brands in this segment. The division began with a sales force of 50 people.

      Acquisitions to enter new therapies.

      Sanzyme: The acquisition of the Sanzyme brands allows the company to enter the probiotics market. The probiotics portfolio includes Sporlac (the third-largest probiotics brand in India).

      There is potential for synergies with the existing brands regarding distribution and doctor outreach, accelerating the acquisition portfolio’s growth.

      Azmarda: J.B. Chemicals acquired Novartis’ patented product Azmarda (sacubitril + valsartan) to strengthen its presence in the cardiology segment.

      Become a global CMO leader

      J.B. Chemicals & Pharmaceuticals Ltd. wants to become a global Contract Manufacturer Organization leader in the medicated and herbal lozenges category.

      CMO is another focus area for new management. They want to leverage their leadership in the lozenges CMO businesses to

      • enter new geographies,
      • add to its global client base, and
      • design and launch new product forms.

      The Contract Manufacturing (CMO) division currently accounts for 11% of J.B.’s consolidated revenues. The primary therapeutic segment is cough and cold. J.B. works with well-known clients (J&J, P&G, Reckitt Benckiser, iNova) and manufactures famous brands such as Vicks, Strepsils, Doktor Mom, and others.

      The company’s leading brands include

      Cilacar is used to treat heart-related conditions like angina (chest pain) and high blood pressure (hypertension).

      Rantac is used to treat indigestion, heartburn and acid reflux.

      Metrogyl is used to treat infections caused by bacteria and other organisms in various body parts. Metrogyl may also be used during surgery to prevent or treat certain infections. Metrogyl is an antibiotic that belongs to the nitroimidazole class of drugs.

      Nicardia works by relaxing the blood vessels, lowering blood pressure and risk of future strokes, heart attacks, heart-related chest pain (angina), other heart problems, or kidney problems.

      Let’s look at the Financials of J.B. Chemicals & Pharmaceuticals Ltd.

      J.B. Chemicals

      Revenue momentum continued in the fourth quarter, clocking solid double-digit growth. Sales growth for Q4 FY22 was 18%. FY22 ended on a strong positive note, with 19% growth YoY.

      EBITDA stood at Rs.125 crores, which was flattish YoY & EBITDA margin at 20% contracted due to sharp increase in operating cost, after adjusting for the one-time acquisition cost of Rs.15.crore for Sanzyme Integration, PAT came at Rs.84.84 crores which were flattish sequentially but de-grew 16% YoY.

      J.B. Chemicals

      To get more detailed analysis and Reports on Stocks, visit our Edge Report Section by subscribing to our StockEdge premium plans.

      Watch our video

      Road Ahead…

      The management of J.B. Chemicals & Pharmaceuticals Ltd. has guided for EBITDA margin to be in the range of 24% to 26% for FY23. The company is exploring inorganic opportunities in India and South Africa. The revenue from new launches will contribute 4 to 5% of sales. The management has also guided two new launches in the lozenges business in India in FY23.

      However, with such pharmaceutical companies, regulatory risks, raw material price inflation risks, and currency risks can impact the company’s profitability.

      So we will have to wait and see how J.B. Chemicals & Pharmaceuticals Ltd. develops from here on out.

      Until then, keep an eye out for the next blog and our midweek and weekend editions of “Trending Stocks and Stock Insights.” Also, please share it with your friends and family.

      Happy Investing!

      Tags: JB Chemicals & Pharmaceuticals Ltd.stock insights
      ShareTweetSend
      Subscribe On Telegram Subscribe On Telegram Subscribe On Telegram
      Previous Post

      Blue Dart Express – A market leader in Air Express Industry

      Next Post

      Elgi Equipments – Enjoying Strong Tailwinds

      StockEdge

      StockEdge

      StockEdge is a self-help Equity and Mutual Fund research tool. It empowers retail investors to identify investment opportunity with all the necessary data and analytics.

      Related Posts

      How Page Industries is creating a “branded” opportunity in a fragmented market
      Insights

      How Page Industries is creating a “branded” opportunity in a fragmented market

      June 26, 2022
      4.1k
      5 Stocks which are Consistently Paying Dividend
      Insights

      5 Stocks which are Consistently Paying Dividend

      June 19, 2022
      30k
      Elgi Equipments – Enjoying Strong Tailwinds
      Insights

      Elgi Equipments – Enjoying Strong Tailwinds

      June 12, 2022
      5.8k
      Next Post
      Elgi Equipments – Enjoying Strong Tailwinds

      Elgi Equipments - Enjoying Strong Tailwinds

      StockEdge Version 8.1 – It keeps getting Better & Better

      StockEdge Version 8.1 - It keeps getting Better & Better

      5 Stocks which are Consistently Paying Dividend

      5 Stocks which are Consistently Paying Dividend

      Comments 2

      1. Mohd Ayoub gojree says:
        3 weeks ago

        Good scan, j.b chemical is good for longterm investment.

        Reply
      2. KD says:
        3 weeks ago

        Good information about jb chem I hold this stock.

        Reply

      Leave a Reply Cancel reply

      Your email address will not be published. Required fields are marked *

      Contact Us

      • Timing (Mon-Sat): 10 am to 7 pm
      • Sales: +919830994463
      • Support: +919830994402
      • Club Support: +916289906895
      • Affiliate: +917003567131

      Recent Posts

      How Page Industries is creating a “branded” opportunity in a fragmented market

      June 26, 2022

      5 Stocks which are Consistently Paying Dividend

      June 19, 2022

      Important Links

      • StockEdge.com
      • StockEdge Premium
      • - Quarterly Membership
      • - Annual Membership
      • StockEdge Analyst
      • StockEdge Club
      • Compare Plans

      An Initiative Of

      © 2021 Kredent InfoEdge Pvt Ltd.

      Facebook-f Twitter Instagram Linkedin-in Youtube Pinterest-p

      Get StockEdge App

      No Result
      View All Result
      • Home
      • Article Categories
        • Fundamental Analysis
        • Technical Analysis
        • Market Themes
        • StockEdge Tutorials
        • StockEdge Version Updates
      • StockEdge Premium
        • Quarterly Membership
        • Annual Membership
        • StockEdge Analyst
        • StockEdge Club
        • Compare Plans
      • Visit StockEdge.com

      © 2021 Kredent InfoEdge Pvt Ltd.